این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
International Journal of Hematology-Oncology and Stem Cell Research، جلد ۸، شماره ۲، صفحات ۲۱-۲۶
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Evaluating the Survival Rate and the Secondary Malignancies after Treating Hodgkin's Lymphoma Patients with Chemotherapy Regimens.
چکیده انگلیسی مقاله In this study we surveyed the average survival time of the treated Hodgkin's lymphoma patients and also the side effects and malignancies occurring secondary to the treatment. This is a retrospective study of patients referring to Ahwaz's Shafa hospital in a period of 10 years diagnosed with Hodgkin's lymphoma without any age restriction. After gathering all their data, we calculated their survival rate and the chance for a relapse and the secondary malignancies. 389 patients were included in the study with an average age of 27.5 years old and they had received only chemotherapy regimens. 87.9% of them had been treated by ABVD and 12.1 % by Stanford V regimen. 23.1% of them experienced a relapse and 13.1% of all patients, passed away during the study. Secondary malignancies were observed in 11 cases. An overall mean survival time of 295.31 months was resulted. The secondary malignancies after treating Hodgkin's lymphoma patients are different between chemotherapy regimens and chemotherapy - radiotherapy.
کلیدواژه‌های انگلیسی مقاله Chemotherapy,Hodgkin,Second malignancy,Survival
نویسندگان مقاله احمد احمدزاده | ahmad ahmadzadeh
health research institute, research center of thalassemia amp;amp; hemoglobinopathy,ahvaz jundishapur university of medical sciences, ahvaz, iran.

سازمان اصلی تایید شده: دانشگاه علوم پزشکی جندی شاپور اهواز (Ahvaz jundishapur university of medical sciences)

میر سعید یکانی نژاد | mir saeed yekaninejad
department of epidemiology and biostatistics, school of public health, tehran university of medical sciences, tehran, iran.

سازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)

محمد h جلیلی | mohamad h jalili
department of internal medicine, school of medicine, tehran university of medical sciences, tehran, iran.

سازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)

محمد بهادرام | mohammad bahadoram
department of internal medicine, school of medicine, ahvaz jundishapur university of medical science, ahvaz, iran.


مهدی افاضت | mehdi efazat
department of internal medicine, school of medicine, ahvaz jundishapur university of medical science, ahvaz, iran.


محمد ثقه الاسلامی | mohammad seghatoleslami
health research institute, research center of thalassemia amp;amp; hemoglobinopathy,ahvaz jundishapur university of medical sciences, ahvaz, iran.

سازمان اصلی تایید شده: دانشگاه علوم پزشکی جندی شاپور اهواز (Ahvaz jundishapur university of medical sciences)

فاطمه یزدی | fatemeh yazdi
department of internal medicine, ganjavian hospital, ahvaz jundishapur university of medical science, ahvaz, iran.


مژده مهدی پور | mozhdeh mahdipour
department of surgery, arvand hospital, ahvaz jundishapur university of medical science, ahvaz, iran.


آرمیتا ولی زاده | armita valizadeh
department of anatomy, ahvaz jundishapur university of medical sciences, ahvaz, iran.

سازمان اصلی تایید شده: دانشگاه علوم پزشکی جندی شاپور اهواز (Ahvaz jundishapur university of medical sciences)

نجم الدین ساکی | najmaldin saki
health research institute, research center of thalassemia amp;amp; hemoglobinopathy,ahvaz jundishapur university of medical sciences, ahvaz, iran.

سازمان اصلی تایید شده: دانشگاه علوم پزشکی جندی شاپور اهواز (Ahvaz jundishapur university of medical sciences)

نشانی اینترنتی http://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/424
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده Articles
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات